Latest Earnings Results: Q2 '26
Estimated EPS
$0.83
Reported EPS
$0.86
Surprise
+3.9%
Estimated Rev
$5.36B
Reported Rev
$5.44B
Surprise
+1.44%
$BSX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.62 up 14.81% YoY • Reported revenue of $5.44B up 7.53% YoY • Boston Scientific estimates third quarter 2026 net sales growth of 3 to 5 percent and adjusted EPS of $0.80 to $0.82, with full year 2026 adjusted EPS of $3.28 to $3.32.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.81 | -- | -- | N/A |
Q2 '26 | $0.83 | $0.86 | 3.90% | BEAT |
Q1 '26 | $0.79 | $0.80 | 1.51% | BEAT |
Q4 '25 | $0.78 | $0.80 | 2.56% | BEAT |
Q3 '25 | $0.71 | $0.75 | 5.29% | BEAT |